Verona Pharma plc
VRNADelisted Oct 7, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001657312
Verona Pharma plc was delisted on Oct 7, 2025; its insiders filed their last Form 4 on Oct 8, 2025; 243 institutions reported holding it in 13F filings for Q3 2025, worth $8.57B in total; superinvestors Duquesne Family Office and Soros Fund Management held it.
13F holders, Q3 2021
Institutional positions in Verona Pharma plc as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +3 vs. Q2 2021
- Shares held
- 37.0M
- +318.9K (+0.9%) vs. Q2 2021
- Total value
- $202.7M
- −$37.2M (−15.5%) vs. Q2 2021
- New holders
- 8
- 9 more added
- Sold out
- 5
- 4 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 243 | $8.57B |
| Q2 2025 | 292 | $7.18B |
| Q1 2025 | 258 | $4.58B |
| Q4 2024 | 191 | $3.19B |
| Q3 2024 | 150 | $1.95B |
| Q2 2024 | 125 | $957.0M |
| Q1 2024 | 113 | $1.08B |
| Q4 2023 | 117 | $1.35B |
| Q3 2023 | 102 | $1.07B |
| Q2 2023 | 105 | $1.33B |
| Q1 2023 | 95 | $1.21B |
| Q4 2022 | 88 | $1.31B |
| Q3 2022 | 68 | $529.0M |
| Q2 2022 | 40 | $145.9M |
| Q1 2022 | 39 | $181.7M |
| Q4 2021 | 42 | $248.0M |
| Q3 2021 | 40 | $202.7M |
| Q2 2021 | 37 | $239.9M |
| Q1 2021 | 37 | $305.1M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Verona Pharma plc; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Barclays PLC | 12 | $0 | 0.00% | +2+20.0% | Added |
| Deutsche Bank AG | 59 | $0 | 0.00% | +1+1.7% | Added |
| Fifth Third Bancorp | 1,000 | $5.00K | 0.00% | 00.0% | Unchanged |
| Plante Moran Financial Advisors, LLC | 892 | $5.00K | 0.00% | +892 | New |
| UBS Group AG | 879 | $5.00K | 0.00% | +879 | New |
| Migdal Insurance & Financial Holdings Ltd. | 1,324 | $7.00K | 0.00% | +1,324 | New |
| Tower Research Capital LLC (TRC) | 1,777 | $10.0K | 0.00% | +412+30.2% | Added |
| Parallel Advisors, LLC | 2,000 | $11.0K | 0.00% | 00.0% | Unchanged |
| US Bancorp | 3,840 | $21.0K | 0.00% | 00.0% | Unchanged |
| Brewin Dolphin Ltd | 4,415 | $24.2K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 8,194 | $45.0K | 0.00% | +4,520+123.0% | Added |
| Geode Capital Management, LLC | 10,707 | $58.0K | 0.00% | +10,707 | New |
| Bank of America Corp | 11,070 | $60.0K | 0.00% | +7,715+230.0% | Added |
| Rathbone Brothers plc | 11,959 | $66.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 14,786 | $81.0K | 0.00% | +14,786 | New |
| HSBC Holdings PLC | 15,041 | $83.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 15,364 | $84.0K | 0.00% | +15,364 | New |
| IHT Wealth Management, LLC | 18,560 | $102.0K | 0.01% | 00.0% | Unchanged |
| Citadel Advisors LLC | 22,870 | $125.0K | 0.00% | +22,870 | New |
| Forefront Analytics, LLC | 33,156 | $181.0K | 0.07% | +17,650+113.8% | Added |
| D.A. Davidson & Co. | 40,000 | $219.0K | 0.00% | −1,900−4.5% | Reduced |
| Schonfeld Strategic Advisors LLC | 58,600 | $321.0K | 0.00% | +400+0.7% | Added |
| venBio Partners LLC | 161,897 | $887.0K | 0.09% | 00.0% | Unchanged |
| BlackRock Inc. | 245,594 | $1.35M | 0.00% | −4,347−1.7% | Reduced |
| Citigroup Inc | 495,446 | $2.71M | 0.00% | +495,446 | New |
| Ghost Tree Capital, LLC | 750,000 | $4.11M | 1.36% | −250,000−25.0% | Reduced |
| Tekla Capital Management LLC | 751,905 | $4.12M | 0.13% | 00.0% | Unchanged |
| Novo Holdings A/S | 761,205 | $4.17M | 0.22% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 801,256 | $4.39M | 0.44% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 926,602 | $5.08M | 1.85% | +842,658+1,003.8% | Added |
| Foresite Capital Management III, LLC | 1,111,112 | $6.09M | 8.44% | 00.0% | Unchanged |
| Samsara BioCapital, LLC | 1,111,112 | $6.09M | 1.01% | 00.0% | Unchanged |
| Aisling Capital Management LP | 1,332,485 | $7.30M | 1.46% | 00.0% | Unchanged |
| Abingworth LLP | 2,457,499 | $13.4M | 3.04% | 00.0% | Unchanged |
| Vivo Capital, LLC | 2,749,918 | $15.1M | 0.68% | −298,589−9.8% | Reduced |
| Perceptive Advisors LLC | 2,888,889 | $15.8M | 0.23% | 00.0% | Unchanged |
| Wellington Management Group LLP | 4,294,038 | $23.5M | 0.00% | +382,198+9.8% | Added |
| Ra Capital Management, L.P. | 5,100,000 | $27.9M | 0.39% | 00.0% | Unchanged |
| NEA Management Company, LLC | 5,108,563 | $27.9M | 0.35% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 5,694,841 | $31.2M | 0.35% | 00.0% | Unchanged |
| Polar Capital Holdings Plc | 0 | $0 | 0.00% | −900,000−100.0% | Sold out |
| Wedbush Securities Inc | 0 | $0 | 0.00% | −18,035−100.0% | Sold out |
| Quantitative Systematic Strategies LLC | 0 | $0 | 0.00% | −14,034−100.0% | Sold out |
| Chicago Partners Investment Group LLC | 0 | $0 | 0.00% | −10,006−100.0% | Sold out |
| Endurance Wealth Management, Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |